Affluent Medical announces a new capital increase

Affluent Medical announced the provision of a prospectus for the admission of 6,190,831 new shares on Euronext Paris. These shares were issued following a capital increase with elimination of shareholders' preferential subscription rights, for a total amount of 8.54 million euros.

The subscription price for the new shares was set at 1.38 euros, a discount of 15% compared to the average of the last 20 trading sessions. This operation notably enabled Edwards Lifesciences to become a 9.21% shareholder in the company, against an investment of 5 million euros.

Following this capital increase, the capital of Affluent Medical is made up of 39,336,524 shares. A shareholder holding 1% of the capital before the operation would now be diluted to 0.84%.

The prospectus is available on the AMF and Affluent Medical websites. The AMF points out that its validation does not constitute a favorable opinion on the securities issued.